Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ACCURAY INCARAY · Entity 1170 | Director | November 28, 2025 | December 02, 2025 |
| SI-BONE, Inc.SIBN · Entity 2501 | Director | June 04, 2026 | June 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ACCURAY INC
Report date November 28, 2025 · Filed December 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 56,603 |
Reported balance
After 2025-11-28 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-11-28 · Grant · Acquired 56,603 · Balance 56,603 F1: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2: This represents a Restricted Stock Unit that vests 100% on 11/13/2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2: This represents a Restricted Stock Unit that vests 100% on 11/13/2026.
SI-BONE, Inc.
Report date June 04, 2026 · Filed June 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 43,673 |
Reported balance
After 2026-06-04 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-04 · Grant · Acquired 10,957 · Balance 43,673 F1: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest 100% upon the earlier of (i) the next annual general meeting of the stockholders of the Company or (ii) the date one year from the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Company's Board of Directors until such date. F2: Includes 10,957 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest 100% upon the earlier of (i) the next annual general meeting of the stockholders of the Company or (ii) the date one year from the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Company's Board of Directors until such date.
F2: Includes 10,957 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 04, 2026 Filed Jun 8, 2026 21:42 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 10,957 | $0.00 | $0.00 |
DisclosureSEC source: 0001848327-26-000002 · primarydocument.xml · nonDerivative · entry 1 Nishimura Mika · CIK 0001848327 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,673 F1 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest 100% upon the earlier of (i) the next annual general meeting of the stockholders of the Company or (ii) the date one year from the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Company's Board of Directors until such date. F2 · balance_after: Includes 10,957 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 12, 2026 Filed Mar 13, 2026 21:07 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 4,100 | $13.83 | $56,700.13 |
DisclosureSEC source: 0001848327-26-000001 · primarydocument.xml · nonDerivative · entry 1 Nishimura Mika · CIK 0001848327 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,716 F1 · price: This transaction was executed in multiple trades at prices ranging from $13.82 USD to $13.86 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes 8,675 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| November 28, 2025 Filed Dec 2, 2025 22:25 UTC | ACCURAY INC ARAY · Entity 1170 | GrantRestricted Stock Units · Derivative | 56,603 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001214659-25-017514 · marketforms-71393.xml · derivative · entry 1 Nishimura Mika · CIK 0001848327 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,603 Underlying: Common Stock · 56,603 shares Expires not disclosed F1 · security: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: This represents a Restricted Stock Unit that vests 100% on 11/13/2026. F2 · derivative.expiration_date: This represents a Restricted Stock Unit that vests 100% on 11/13/2026. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 22:55 UTC | ACCURAY INC ARAY · Entity 1170 | Exercise / conversionRestricted Stock Units · Derivative | 56,603 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001214659-25-017245 · marketforms-71326.xml · derivative · entry 2 Nishimura Mika · CIK 0001848327 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 56,603 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: This represents a Restricted Stock Unit that vests 100% on 11/21/2025. F2 · derivative.expiration_date: This represents a Restricted Stock Unit that vests 100% on 11/21/2025. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 22:55 UTC | ACCURAY INC ARAY · Entity 1170 | Exercise / conversionCommon Stock | 56,603 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-25-017245 · marketforms-71326.xml · nonDerivative · entry 1 Nishimura Mika · CIK 0001848327 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 212,659 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 23:46 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 8,675 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-004611 · primarydocument.xml · nonDerivative · entry 1 Nishimura Mika · CIK 0001848327 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,816 F1 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest 100% upon the earlier of (i) the next annual general meeting of the stockholders of the Company or (ii) the date one year from the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Company's Board of Directors until such date. F2 · balance_after: Includes 8,675 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 21:20 UTC | ACCURAY INC ARAY · Entity 1170 | GrantRestricted Stock Units · Derivative | 56,603 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001214659-24-019898 · marketforms-67454.xml · derivative · entry 1 Nishimura Mika · CIK 0001848327 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,603 Underlying: Common Stock · 56,603 shares Expires not disclosed F1 · security: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: This represents a Restricted Stock Unit that vests 100% on 11/21/2025. F2 · derivative.expiration_date: This represents a Restricted Stock Unit that vests 100% on 11/21/2025. Read SEC document |
| June 26, 2024 Filed Jun 27, 2024 21:51 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 8,791 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-005331 · primarydocument.xml · nonDerivative · entry 1 Nishimura Mika · CIK 0001848327 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,141 F1 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest 100% upon the earlier of (i) the next annual general meeting of the stockholders of the Company or (ii) the date one year from the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Company's Board of Directors until such date. F2 · balance_after: Includes 8,791 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 13, 2024 Filed Mar 14, 2024 21:45 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 2,500 | $16.22 | $40,550.00 |
DisclosureSEC source: 0001562180-24-002690 · primarydocument.xml · nonDerivative · entry 1 Nishimura Mika · CIK 0001848327 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,350 F1 · balance_after: Includes 5,550 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| November 30, 2023 Filed Dec 5, 2023 01:50 UTC | ACCURAY INC ARAY · Entity 1170 | GrantCommon Stock | 56,603 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-23-016012 · marketforms-63684.xml · nonDerivative · entry 1 Nishimura Mika · CIK 0001848327 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,056 F1 · shares: This represents a Restricted Stock Unit that vests 100% on 11/9/2024. Read SEC document |
| June 09, 2023 Filed Jun 13, 2023 20:30 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 4,866 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005113 · primarydocument.xml · nonDerivative · entry 1 Nishimura Mika · CIK 0001848327 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,850 F1 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest 100% upon the earlier of (i) the next annual general meeting of the stockholders of the Company or (ii) the date one year from the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Company's Board of Directors until such date. F2 · balance_after: Includes 4,866 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| November 30, 2022 Filed Dec 7, 2022 21:45 UTC | ACCURAY INC ARAY · Entity 1170 | GrantCommon Stock | 59,055 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-22-014664 · marketforms-57820.xml · nonDerivative · entry 1 Nishimura Mika · CIK 0001848327 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,453 F1 · shares: This represents a Restricted Stock Unit that vest 100% on 11/10/2023. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 20:06 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 8,324 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-005237 · primarydocument.xml · nonDerivative · entry 1 Nishimura Mika · CIK 0001848327 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,984 F1 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest 100% upon the earlier of (i) the next annual general meeting of the stockholders of the Company or (ii) the date one year from the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Company's Board of Directors until such date. F2 · balance_after: Includes 13,115 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 21:59 UTC | ACCURAY INC ARAY · Entity 1170 | GrantCommon Stock | 31,185 | $4.81 | $149,999.85 |
DisclosureSEC source: 0001214659-21-012597 · marketforms-54459.xml · nonDerivative · entry 1 Nishimura Mika · CIK 0001848327 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,398 F1 · shares: This represents a Restricted Stock Unit that vest 100% on 11/19/2022. Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 20:25 UTC | ACCURAY INC ARAY · Entity 1170 | GrantCommon Stock | 9,213 | $4.07 | $37,496.91 |
DisclosureSEC source: 0001214659-21-009288 · marketforms-53708.xml · nonDerivative · entry 1 Nishimura Mika · CIK 0001848327 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,213 F1 · shares: This represents a Restricted Stock Unit grant that vest 100% on 11/20/2021. Read SEC document |
| March 04, 2021 Filed Mar 8, 2021 21:40 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 8,213 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-002063 · primarydocument.xml · nonDerivative · entry 2 Nishimura Mika · CIK 0001848327 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,660 F2 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will be vesting in a series of 12 equal quarterly increments starting on the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Issuer's Board of Directors on each applicable vesting date. Read SEC document |
| March 04, 2021 Filed Mar 8, 2021 21:40 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 447 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-002063 · primarydocument.xml · nonDerivative · entry 1 Nishimura Mika · CIK 0001848327 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 447 F1 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will be vesting 100% upon the earlier of (i) the next annual general meeting of the stockholders of the Company or (ii) the date one year from the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Company's Board of Directors until such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.